30778597|t|Effect of Intravenous Acetaminophen vs Placebo Combined With Propofol or Dexmedetomidine on Postoperative Delirium Among Older Patients Following Cardiac Surgery: The DEXACET Randomized Clinical Trial.
30778597|a|Importance: Postoperative delirium is common following cardiac surgery and may be affected by choice of analgesic and sedative. Objective: To evaluate the effect of postoperative intravenous (IV) acetaminophen (paracetamol) vs placebo combined with IV propofol vs dexmedetomidine on postoperative delirium among older patients undergoing cardiac surgery. Design, Setting, and Participants: Randomized, placebo-controlled, factorial clinical trial among 120 patients aged 60 years or older undergoing on-pump coronary artery bypass graft (CABG) surgery or combined CABG/valve surgeries at a US center. Enrollment was September 2015 to April 2018, with follow-up ending in April 2019. Interventions: Patients were randomized to 1 of 4 groups receiving postoperative analgesia with IV acetaminophen or placebo every 6 hours for 48 hours and postoperative sedation with dexmedetomidine or propofol starting at chest closure and continued for up to 6 hours (acetaminophen and dexmedetomidine: n = 29; placebo and dexmedetomidine: n = 30; acetaminophen and propofol: n = 31; placebo and propofol: n = 30). Main Outcomes and Measures: The primary outcome was incidence of postoperative in-hospital delirium by the Confusion Assessment Method. Secondary outcomes included delirium duration, cognitive decline, breakthrough analgesia within the first 48 hours, and ICU and hospital length of stay. Results: Among 121 patients randomized (median age, 69 years; 19 women [15.8%]), 120 completed the trial. Patients treated with IV acetaminophen had a significant reduction in delirium (10% vs 28% placebo; difference, -18% [95% CI, -32% to -5%]; P = .01; HR, 2.8 [95% CI, 1.1-7.8]). Patients receiving dexmedetomidine vs propofol had no significant difference in delirium (17% vs 21%; difference, -4% [95% CI, -18% to 10%]; P = .54; HR, 0.8 [95% CI, 0.4-1.9]). There were significant differences favoring acetaminophen vs placebo for 3 prespecified secondary outcomes: delirium duration (median, 1 vs 2 days; difference, -1 [95% CI, -2 to 0]), ICU length of stay (median, 29.5 vs 46.7 hours; difference, -16.7 [95% CI, -20.3 to -0.8]), and breakthrough analgesia (median, 322.5 vs 405.3 microg morphine equivalents; difference, -83 [95% CI, -154 to -14]). For dexmedetomidine vs propofol, only breakthrough analgesia was significantly different (median, 328.8 vs 397.5 microg; difference, -69 [95% CI, -155 to -4]; P = .04). Fourteen patients in both the placebo-dexmedetomidine and acetaminophen-propofol groups (46% and 45%) and 7 in the acetaminophen-dexmedetomidine and placebo-propofol groups (24% and 23%) had hypotension. Conclusions and Relevance: Among older patients undergoing cardiac surgery, postoperative scheduled IV acetaminophen, combined with IV propofol or dexmedetomidine, reduced in-hospital delirium vs placebo. Additional research, including comparison of IV vs oral acetaminophen and other potentially opioid-sparing analgesics, on the incidence of postoperative delirium is warranted. Trial Registration: ClinicalTrials.gov Identifier: NCT02546765.
30778597	22	35	Acetaminophen	Chemical	MESH:D000082
30778597	61	69	Propofol	Chemical	MESH:D015742
30778597	73	88	Dexmedetomidine	Chemical	MESH:D020927
30778597	92	114	Postoperative Delirium	Disease	MESH:D000071257
30778597	127	135	Patients	Species	9606
30778597	214	236	Postoperative delirium	Disease	MESH:D000071257
30778597	398	411	acetaminophen	Chemical	MESH:D000082
30778597	413	424	paracetamol	Chemical	MESH:D000082
30778597	454	462	propofol	Chemical	MESH:D015742
30778597	466	481	dexmedetomidine	Chemical	MESH:D020927
30778597	485	507	postoperative delirium	Disease	MESH:D000071257
30778597	520	528	patients	Species	9606
30778597	659	667	patients	Species	9606
30778597	900	908	Patients	Species	9606
30778597	984	997	acetaminophen	Chemical	MESH:D000082
30778597	1068	1083	dexmedetomidine	Chemical	MESH:D020927
30778597	1087	1095	propofol	Chemical	MESH:D015742
30778597	1155	1168	acetaminophen	Chemical	MESH:D000082
30778597	1173	1188	dexmedetomidine	Chemical	MESH:D020927
30778597	1210	1225	dexmedetomidine	Chemical	MESH:D020927
30778597	1235	1248	acetaminophen	Chemical	MESH:D000082
30778597	1253	1261	propofol	Chemical	MESH:D015742
30778597	1283	1291	propofol	Chemical	MESH:D015742
30778597	1393	1401	delirium	Disease	MESH:D003693
30778597	1466	1474	delirium	Disease	MESH:D003693
30778597	1485	1502	cognitive decline	Disease	MESH:D003072
30778597	1610	1618	patients	Species	9606
30778597	1656	1661	women	Species	9606
30778597	1697	1705	Patients	Species	9606
30778597	1722	1735	acetaminophen	Chemical	MESH:D000082
30778597	1767	1775	delirium	Disease	MESH:D003693
30778597	1874	1882	Patients	Species	9606
30778597	1893	1908	dexmedetomidine	Chemical	MESH:D020927
30778597	1912	1920	propofol	Chemical	MESH:D015742
30778597	1954	1962	delirium	Disease	MESH:D003693
30778597	2096	2109	acetaminophen	Chemical	MESH:D000082
30778597	2160	2168	delirium	Disease	MESH:D003693
30778597	2385	2393	morphine	Chemical	MESH:D009020
30778597	2451	2466	dexmedetomidine	Chemical	MESH:D020927
30778597	2470	2478	propofol	Chemical	MESH:D015742
30778597	2625	2633	patients	Species	9606
30778597	2654	2669	dexmedetomidine	Chemical	MESH:D020927
30778597	2674	2687	acetaminophen	Chemical	MESH:D000082
30778597	2688	2696	propofol	Chemical	MESH:D015742
30778597	2731	2744	acetaminophen	Chemical	MESH:D000082
30778597	2745	2760	dexmedetomidine	Chemical	MESH:D020927
30778597	2773	2781	propofol	Chemical	MESH:D015742
30778597	2807	2818	hypotension	Disease	MESH:D007022
30778597	2859	2867	patients	Species	9606
30778597	2923	2936	acetaminophen	Chemical	MESH:D000082
30778597	2955	2963	propofol	Chemical	MESH:D015742
30778597	2967	2982	dexmedetomidine	Chemical	MESH:D020927
30778597	3004	3012	delirium	Disease	MESH:D003693
30778597	3081	3094	acetaminophen	Chemical	MESH:D000082
30778597	3164	3186	postoperative delirium	Disease	MESH:D000071257
30778597	Cotreatment	MESH:D000082	MESH:D015742
30778597	Cotreatment	MESH:D015742	MESH:D020927
30778597	Negative_Correlation	MESH:D000082	MESH:D000071257
30778597	Positive_Correlation	MESH:D000082	MESH:D007022
30778597	Negative_Correlation	MESH:D000082	MESH:D003693
30778597	Cotreatment	MESH:D000082	MESH:D020927
30778597	Association	MESH:D009020	MESH:D007022
30778597	Negative_Correlation	MESH:D020927	MESH:D000071257
30778597	Negative_Correlation	MESH:D015742	MESH:D000071257

